Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL21P98 (Ribosomal protein L21 pseudogene 98) is a human processed pseudogene, meaning it is a non-functional DNA segment that resembles the functional ribosomal protein L21 gene but does not encode a functional protein[10]. Pseudogenes like RPL21P98 typically arise from duplication or retrotransposition events and lack the ability to produce active protein products[10]. RPL21P98 is not associated with any known disease, molecular function, or drug interactions, and it does not serve as a therapeutic target[10]. The functional version of the gene, RPL21, encodes a structural protein of the ribosome 60S subunit, but pseudogenes such as RPL21P98 do not contribute to ribosomal structure or function[7][8][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L21 pseudogene 98 (RPL21P98).